In a filing, Idexx Laboratories, Inc revealed its Director SZOSTAK M ANNE unloaded Company’s shares for reported $1.42 million on Aug 22 ’25. In the deal valued at $647.33 per share,2,187 shares were sold. As a result of this transaction, SZOSTAK M ANNE now holds 262 shares worth roughly $0.17 million.
Then, MARGARET ANNE SZOSTAK bought 2,187 shares, generating $1,415,700 in total proceeds.
Before that, Erickson Michael G sold 406 shares. Idexx Laboratories, Inc shares valued at $263,813 were divested by the Executive Vice President at a price of $649.96 per share. As a result of the transaction, Erickson Michael G now holds 11,287 shares, worth roughly $7.41 million.
BTIG Research reiterated its Idexx Laboratories, Inc [IDXX] rating to a Buy in a research note published on August 05, 2025; the price target was $785. A number of analysts have revised their coverage, including Jefferies’s analysts, who began to cover the stock in early July with a ‘”a Buy”‘ rating. Leerink Partners began covering IDXX with “an Outperform” recommendation on December 02, 2024. BTIG Research started covering the stock on July 25, 2024. It rated IDXX as “a Buy”.
Price Performance Review of IDXX
On Friday, Idexx Laboratories, Inc [NASDAQ:IDXX] saw its stock jump 0.10% to $656.16. Over the last five days, the stock has gained 2.34%. Idexx Laboratories, Inc shares have risen nearly 28.09% since the year began. Nevertheless, the stocks have risen 58.71% over the past one year.
How much short interest is there in Idexx Laboratories, Inc?
A steep rise in short interest was recorded in Idexx Laboratories, Inc stocks on 2025-08-29, dropping by -0.43 million shares to a total of 2.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 2.48 million shares. There was a decline of -21.09%, which implies that there is a negative sentiment for the stock.
